PYXS · Pyxis Oncology, Inc.
$3.23
-0.09 (-2.71%)
At close · Aug 28
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern for one year from the date these unaudited condensed consolidated financial statements were issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$269.41M
Shares
83.41M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-31 | 4,038 | $2.87 | $11,589 |
| 2026-07-30 | 9,589 | $2.92 | $28,000 |
| 2026-07-28 | 5 | $2.91 | $15 |
| 2026-07-27 | 7,246 | $2.61 | $18,912 |
| 2026-07-17 | 3,244 | $2.23 | $7,234 |
| 2026-07-13 | 14,206 | $2.67 | $37,930 |
| 2026-07-08 | 61,003 | $3.07 | $187,279 |
| 2026-07-06 | 70 | $2.63 | $184 |
| 2026-07-01 | 14,020 | $3.01 | $42,200 |
| 2026-06-30 | 4,274 | $2.86 | $12,224 |
| 2026-06-29 | 39,484 | $2.77 | $109,371 |
Showing 1–11 of 11 settlements
Key facts
CIK
1782223
CUSIP
747324101
13F (30d)
73 filings
71 filers
Visit website
Investor relations